Sign in
SCHEDULE 13D/A

Beneficial Ownership Report

Atara Biotherapeutics, Inc. Filed Acc 0001104659-26-061506

Stakes reported in this filing

Reporting person Shares Of the class
Redmile Group, LLC 950,994 9.9%
Jeremy C. Green 950,994 9.9%
Redmile Biopharma Investments II, L.P. 651,924 6.9%
Redmile Strategic Long Only Trading Sub, Ltd. 576,148 6.1%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13D_X02/primary_doc.xml…